[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.167.151.77. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
November 26, 2008

Sildenafil as Treatment for Antidepressant-Induced Sexual Dysfunction—Reply

JAMA. 2008;300(20):2365-2366. doi:10.1001/jama.2008.694

In Reply: Dr Harinstein raises concerns that treatment with additional medication such as sildenafil can add to patient adverse effects and cost burdens and suggests further consideration of different management options. Although we agree that no single treatment is definitive, the large number of reports evaluating treatment modalities (including SRI agonists, antagonists, partial agonists, switching, or augmentation, or nonpharmacological approaches such as waiting, drug holiday, or dose reduction) include only a few randomized clinical trials. With the exception of phosphodiesterase type 5 inhibitors,1 no clinically meaningful and significant data support those treatment modalities, leaving patients at risk for excess random pharmacology.2

First Page Preview View Large
First page PDF preview
First page PDF preview
×